Surveillance for renal cell carcinoma: Why and how? When and how often?
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference32 articles.
1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007
2. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma;Zisman;J Clin Oncol,2002
3. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumor nephrectomy: Results of a prospectively randomized trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN);Atzpodien;Br J Cancer,2005
4. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: A cytokine working group randomized trial;Clark;J Clin Oncol,2003
5. Phase III study of interferon α-NL as adjuvant treatment for resectable renal cell carcinoma: An Eastern Cooperative Oncology Group/Intergroup trial;Messing;J Clin Oncol,2003
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current evidence on screening for renal cancer;Nature Reviews Urology;2020-08-28
2. Ablation of Renal Cell Carcinoma;Image-Guided Interventions;2020
3. Unified Approaches to Surgery and Systemic Therapy for Renal Cell Carcinoma;Renal Cancer;2019-10-17
4. Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma;RadioGraphics;2019-07
5. Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival;Clinical Genitourinary Cancer;2019-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3